<?xml version="1.0" encoding="UTF-8"?>
<p>Among the 102 patients, three did not receive antiviral therapy (either oseltamivir or peramivir). Of the 99 patients who received antiviral therapy, 89 patients received oseltamivir and five received peramivir; five patients received both oseltamivir and peramivir during their hospitalization. Of the 94 patients who received oseltamivir therapy, 68 (72.3%) began taking oseltamivir 48 h after the onset of illness. Among the 10 patients who received peramivir, 60% received antiviral therapy 48 h after the onset of symptoms. Among 102 patients, influenza A virus was detected in 77 (75.5%) patients (33.3% for pdm09 A/H1, 7.8% for H3N2 and 28.4% for untypable influenza A), influenza B virus in 24 (23.5%), and concurrent influenza A (untypable) and influenza B in 1 (0.9%). The clinical characteristics of the included patients are summarized in 
 <xref rid="jcm-09-01073-t001" ref-type="table">Table 1</xref> and 
 <xref rid="jcm-09-01073-t002" ref-type="table">Table 2</xref>.
</p>
